Research priorities for peripheral artery disease: A statement from the Society for Vascular Medicine.
McDermott MM, Kadian-Dodov D, Aronow HA, Beckman JA, Bolden DM, Castro-Dominguez YS, Creager MA, Criqui MH, Goodney PP, Gornik HL, Hamburg NM, Leeper NJ, Olin JW, Ross E, Bonaca MP.
McDermott MM, et al.
Vasc Med. 2025 Jun;30(3):367-383. doi: 10.1177/1358863X251330583. Epub 2025 May 1.
Vasc Med. 2025.
PMID: 40310104
Review.
Despite availability of new therapies that prevent major adverse cardiovascular events (MACE), these and major adverse limb events (MALE) remain common and occur more frequently in people with PAD, either with or without coronary artery disease (CAD), compare …
Despite availability of new therapies that prevent major adverse cardiovascular events (MACE), these and major adverse limb ev …